Pulse Biosciences PLSE Stock
Pulse Biosciences Price Chart
Pulse Biosciences PLSE Financial and Trading Overview
| Pulse Biosciences stock price | 49 USD |
| Previous Close | 50.42 USD |
| Open | 50.01 USD |
| Bid | 35.71 USD x 100 |
| Ask | 49.08 USD x 100 |
| Day's Range | 46.34 - 50.34 USD |
| 52 Week Range | 12.56 - 50.71 USD |
| Volume | 345.86K USD |
| Avg. Volume | 375K USD |
| Market Cap | 3.5B USD |
| Beta (5Y Monthly) | 1.577 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.17 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 45.25 USD |
PLSE Valuation Measures
| Enterprise Value | 3.41B USD |
| Trailing P/E | N/A |
| Forward P/E | -42.5368 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2957.0295 |
| Price/Book (mrq) | 34.96797 |
| Enterprise Value/Revenue | 2876.989 |
| Enterprise Value/EBITDA | -41.265 |
Trading Information
Pulse Biosciences Stock Price History
| Beta (5Y Monthly) | 1.577 |
| 52-Week Change | 190.53% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 50.71 USD |
| 52 Week Low | 12.56 USD |
| 50-Day Moving Average | 33.46 USD |
| 200-Day Moving Average | 22.48 USD |
PLSE Share Statistics
| Avg. Volume (3 month) | 375K USD |
| Avg. Daily Volume (10-Days) | 455.03K USD |
| Shares Outstanding | 71.32M |
| Float | 20.59M |
| Short Ratio | 8.61 |
| % Held by Insiders | 71.04% |
| % Held by Institutions | 15.38% |
| Shares Short | 2.98M |
| Short % of Float | 13.99% |
| Short % of Shares Outstanding | 4.17% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -5823.041% |
| Gross Margin | 0.25% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -44.33% |
| Return on Equity (ttm) | -78.49% |
Income Statement
| Revenue (ttm) | 1.19M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 3K USD |
| EBITDA | -82618000 USD |
| Net Income Avi to Common (ttm) | -80056000 USD |
| Diluted EPS (ttm) | -1.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 101.62M USD |
| Total Cash Per Share (mrq) | 1.43 USD |
| Total Debt (mrq) | 6.77M USD |
| Total Debt/Equity (mrq) | 6.81 USD |
| Current Ratio (mrq) | 9.628 |
| Book Value Per Share (mrq) | 1.405 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -61098000 USD |
| Levered Free Cash Flow (ttm) | -34285248 USD |
Profile of Pulse Biosciences
| Country | United States |
| State | FL |
| City | Miami |
| Address | 601 Brickell Key Drive |
| ZIP | 33131 |
| Phone | 510 906 4600 |
| Website | https://www.pulsebiosciences.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 116 |
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Q&A For Pulse Biosciences Stock
What is a current PLSE stock price?
Pulse Biosciences PLSE stock price today per share is 49 USD.
How to purchase Pulse Biosciences stock?
You can buy PLSE shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pulse Biosciences?
The stock symbol or ticker of Pulse Biosciences is PLSE.
Which industry does the Pulse Biosciences company belong to?
The Pulse Biosciences industry is Medical Instruments & Supplies.
How many shares does Pulse Biosciences have in circulation?
The max supply of Pulse Biosciences shares is 71.32M.
What is Pulse Biosciences Price to Earnings Ratio (PE Ratio)?
Pulse Biosciences PE Ratio is now.
What was Pulse Biosciences earnings per share over the trailing 12 months (TTM)?
Pulse Biosciences EPS is -1.17 USD over the trailing 12 months.
Which sector does the Pulse Biosciences company belong to?
The Pulse Biosciences sector is Healthcare.
Pulse Biosciences PLSE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26151.3 USD — |
+0.66
|
6.53B USD — | 26034.35 USD — | 26225.83 USD — | — - | 6.53B USD — |
|
US Tech Health Care
IXHC
US
|
1378.65 USD — |
+1.27
|
— — | 1366.6 USD — | 1381.83 USD — | — - | — — |
|
US Tech Capital Market Composite
RCMP
US
|
144.77 USD — |
+1.56
|
— — | 143.15 USD — | 144.82 USD — | — - | — — |
- {{ link.label }} {{link}}
